Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT00716066||Recruiting||Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy||
||Other / NIH||
||40||All||up to 70 Years (Child, Adult, Older Adult)||NCT00716066||2260.00
|June 2008||March 31, 2020||December 1, 2021||July 16, 2008||March 8, 2019||